How M.D. was paid
$3.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Garry Neil, M.D.Chief Executive Officer, President and principal executive officer | $590,000 | $2,732,298 | $474,950 | $10,333 | $3,807,581 |
| Taylor BoydChief Business Officer | $116,250 | $3,049,481 | $52,080 | $1,940 | $3,219,751 |
| Mittie Doyle, M.D., FACRChief Medical Officer | $512,500 | $1,030,429 | $229,600 | $8,028 | $1,780,557 |
What changed and why
- $3.8MCEO total compensation decreased to $3,807,581 in 2025 compared to $7,212,749 in 2024.
- $2.7MOption awards for the CEO were $2,732,298 in 2025 down from $4,255,801 in 2024.
- $475KNon-equity incentive plan compensation for the CEO was $474,950 in 2025.
- $3.2MTaylor Boyd joined as Chief Business Officer in October 2025 with total compensation of $3,219,751.
- $1.8MMittie Doyle received total compensation of $1,780,557 in 2025.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.